Activity value 72china Supplier,Last transaction date:
2026-03-16
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shandong habier biopharma co ltd from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 1 transactions, with a transaction quantity of 166 and a transaction weight of 4731.
YearTransactionsQuantityWeight
20251284619955
202611664731
Bill of lading data
<
1/15
>
Trade date
2026/03/16
B/L No.
chkmqd26006833
Suppliers
shandong habier biopharma co ltd
Buyers
global natural association inc.
shandong habier biopharma co ltd is china Supplier,
and primarily engages in the import and export business of products such as sodium hyaluronate,pharmaceutical raw material,hyaluronic acid sodium.
According to the 52wmb.com global trade database, as of 2026-03-16, the company has completed 50 international trades,
with its main trading regions covering united states,pakistan,india etc.
The core products include HS382312,HS291815,HS39139090 etc,
often transported via 57047, qingdao,port qingdao, port ching tao etc,
and its main trading partners are a a international pharmachem inc.,global natural association inc.,helix pharm pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shandong habier biopharma co ltd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.